Copyright Reports & Markets. All rights reserved.

Global and Japan Noninvasive Prenatal Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Services
    • 1.2.3 Instrument
  • 1.3 Market by Application
    • 1.3.1 Global Noninvasive Prenatal Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital
    • 1.3.3 Personal
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Noninvasive Prenatal Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Noninvasive Prenatal Diagnostics Growth Trends by Regions
    • 2.2.1 Noninvasive Prenatal Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Noninvasive Prenatal Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Noninvasive Prenatal Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Noninvasive Prenatal Diagnostics Players by Market Size
    • 3.1.1 Global Top Noninvasive Prenatal Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Noninvasive Prenatal Diagnostics Revenue
  • 3.4 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio
    • 3.4.1 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Prenatal Diagnostics Revenue in 2019
  • 3.5 Key Players Noninvasive Prenatal Diagnostics Area Served
  • 3.6 Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Noninvasive Prenatal Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Noninvasive Prenatal Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Type (2021-2026)

5 Noninvasive Prenatal Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Noninvasive Prenatal Diagnostics Market Size (2015-2026)
  • 6.2 North America Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Noninvasive Prenatal Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Noninvasive Prenatal Diagnostics Market Size (2015-2026)
  • 7.2 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Noninvasive Prenatal Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Noninvasive Prenatal Diagnostics Market Size (2015-2026)
  • 8.2 China Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Noninvasive Prenatal Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Noninvasive Prenatal Diagnostics Market Size (2015-2026)
  • 9.2 Japan Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Noninvasive Prenatal Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Noninvasive Prenatal Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Natera
    • 11.1.1 Natera Company Details
    • 11.1.2 Natera Business Overview
    • 11.1.3 Natera Noninvasive Prenatal Diagnostics Introduction
    • 11.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020))
    • 11.1.5 Natera Recent Development
  • 11.2 Illumina
    • 11.2.1 Illumina Company Details
    • 11.2.2 Illumina Business Overview
    • 11.2.3 Illumina Noninvasive Prenatal Diagnostics Introduction
    • 11.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.2.5 Illumina Recent Development
  • 11.3 BGI Diagnosis
    • 11.3.1 BGI Diagnosis Company Details
    • 11.3.2 BGI Diagnosis Business Overview
    • 11.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Introduction
    • 11.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.3.5 BGI Diagnosis Recent Development
  • 11.4 Ariosa Diagnostics
    • 11.4.1 Ariosa Diagnostics Company Details
    • 11.4.2 Ariosa Diagnostics Business Overview
    • 11.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Introduction
    • 11.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.4.5 Ariosa Diagnostics Recent Development
  • 11.5 Quest Diagnostics
    • 11.5.1 Quest Diagnostics Company Details
    • 11.5.2 Quest Diagnostics Business Overview
    • 11.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
    • 11.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.5.5 Quest Diagnostics Recent Development
  • 11.6 Premaitha Health
    • 11.6.1 Premaitha Health Company Details
    • 11.6.2 Premaitha Health Business Overview
    • 11.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Introduction
    • 11.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.6.5 Premaitha Health Recent Development
  • 11.7 NIPD Genetics
    • 11.7.1 NIPD Genetics Company Details
    • 11.7.2 NIPD Genetics Business Overview
    • 11.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Introduction
    • 11.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.7.5 NIPD Genetics Recent Development
  • 11.8 Labcorp
    • 11.8.1 Labcorp Company Details
    • 11.8.2 Labcorp Business Overview
    • 11.8.3 Labcorp Noninvasive Prenatal Diagnostics Introduction
    • 11.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.8.5 Labcorp Recent Development
  • 11.9 Ravgen
    • 11.9.1 Ravgen Company Details
    • 11.9.2 Ravgen Business Overview
    • 11.9.3 Ravgen Noninvasive Prenatal Diagnostics Introduction
    • 11.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.9.5 Ravgen Recent Development
  • 11.10 LifeCodexx
    • 11.10.1 LifeCodexx Company Details
    • 11.10.2 LifeCodexx Business Overview
    • 11.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Introduction
    • 11.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 11.10.5 LifeCodexx Recent Development
  • 11.11 TrovaGene
    • 10.11.1 TrovaGene Company Details
    • 10.11.2 TrovaGene Business Overview
    • 10.11.3 TrovaGene Noninvasive Prenatal Diagnostics Introduction
    • 10.11.4 TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 10.11.5 TrovaGene Recent Development
  • 11.12 Quest Diagnostics
    • 10.12.1 Quest Diagnostics Company Details
    • 10.12.2 Quest Diagnostics Business Overview
    • 10.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
    • 10.12.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 10.12.5 Quest Diagnostics Recent Development
  • 11.13 Berry Genomics
    • 10.13.1 Berry Genomics Company Details
    • 10.13.2 Berry Genomics Business Overview
    • 10.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Introduction
    • 10.13.4 Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2015-2020)
    • 10.13.5 Berry Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Noninvasive Prenatal Diagnostics Scope and Market Size
    Noninvasive Prenatal Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Noninvasive Prenatal Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Services
    Instrument

    Market segment by Application, split into
    Hospital
    Personal
    Other

    Based on regional and country-level analysis, the Noninvasive Prenatal Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Noninvasive Prenatal Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Natera
    Illumina
    BGI Diagnosis
    Ariosa Diagnostics
    Quest Diagnostics
    Premaitha Health
    NIPD Genetics
    Labcorp
    Ravgen
    LifeCodexx
    TrovaGene
    Quest Diagnostics
    Berry Genomics

    Buy now